Europe PMC
open access
Trends in HPV vaccination among adults aged 27-45 years in the United States
Despite expanded human papillomavirus (HPV) vaccination recommendations via shared clinical decision-making (SCDM) for adults aged 27-45 years (i.e., mid-adults), uptake remains low in the United States. Examining trends in HPV vaccination under SCDM across sociodemographic groups, vaccination sites
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention#1124925
- A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.#1171757
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age#18719
- The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.#901600
- A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years#414346
Record · ID 970728
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive